APLS
Apellis Pharmaceuticals Inc
Price:  
34.64 
USD
Volume:  
1,168,115.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Apellis Probability of Bankruptcy

The Probability of Bankruptcy of Apellis Pharmaceuticals Inc (APLS) is 8.61% . This number represents the probability that Apellis will face financial distress in the next 24 months given its current fundamentals and market conditions.

Multiple factors are taken into account when calculating Apellis's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.

Apellis - ESG ratings

ESG ratings are directly linked to the cost of capital and Apellis's ability to raise funding, both of which can significantly affect the probability of Apellis Pharmaceuticals Inc going bankrupt.

ESG Score 26.98
Environment Score 9.22
Social Score 38.39
Governance Score 33.32
Returns
Historical Returns (5 day) 1.49%
Historical Returns (MTD) 2.09%
Historical Returns (YTD) -42.13%
Historical Returns (13 week) -11.59%
Historical Returns (26 week) -15.62%
Historical Returns (52 week) -42.15%
Efficiency
Asset Turnover 0.83
Receiveable Turnover 3.19
Gross Margin 86.47%
Operating Margin -31.23%
Pretax Margin -34.65%
Net Margin -34.97%
Return on Asset (ROA) -29.19
Return on Equity (ROE) -103.92
Return on Investments (ROI) -37.11
Price Metrics
Market Cap (M) 4,308.87
Enterprise Value (M)
52 Week High 73.78
52 Week Low 24.34
Beta 0.67
Average Volume (10 day) 2.75
Average Volume (3 month) 2.70
Price / Earnings (P/E)
Price / Sales (P/S) 6.02
Earnings
EPS -2.04
Revenue CAGR (5 year)
Risk
Current Ratio 4.36
Quick Ratio 3.60